Suditi Rahematpura

A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats

H. Schmidt, M. R. Hayes, R. Doyle, 2021, Neuropharmacology.

A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors

H. Schmidt, M. R. Hayes, R. Doyle, 2021, Neuroscience & Biobehavioral Reviews.

Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.

Hai Helen Li, Chuanwu Zhu, P. Hayes, 2023, The lancet. Gastroenterology & hepatology.

INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion

Douglas A. Simonetto, D. Simonetto, K. Jamil, 2023, Contemporary clinical trials communications.